300 related articles for article (PubMed ID: 34645130)
1. Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
Shim S; Kang D; Kim N; Han G; Lim J; Kim H; Park J; Lee M; Lee JE; Kim SW; Yu J; Chae BJ; Ryu JM; Nam SJ; Lee SK; Cho J
Cancer Res Treat; 2022 Jul; 54(3):834-841. PubMed ID: 34645130
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.
Cho J; Kang D; Kim IR; Kim WS; Ferrell B; Kim SJ
Cancer Res Treat; 2018 Jan; 50(1):204-211. PubMed ID: 28361524
[TBL] [Abstract][Full Text] [Related]
3. Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (Version 2).
Chan DNS; Choi KC; Ng MSN; Xing W; Law BMH; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
Health Qual Life Outcomes; 2021 Jan; 19(1):17. PubMed ID: 33419447
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the Korean version of the Pittsburgh Fatigability Scale in breast cancer survivors.
Jang MK; Kim S; Park CG; Collins EG; Quinn LT; Glynn NW; Ferrans CE
Health Qual Life Outcomes; 2021 Jul; 19(1):179. PubMed ID: 34247645
[TBL] [Abstract][Full Text] [Related]
5. Reliability and validity testing of the Korean translation of lymphedema quality of life questionnaire (LYMQOL) for lower limb lymphedema.
Yeo SM; Uhm KE; Yoo JS; Hwang JH
Disabil Rehabil; 2023 Jul; 45(15):2533-2538. PubMed ID: 36073741
[TBL] [Abstract][Full Text] [Related]
6. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
[TBL] [Abstract][Full Text] [Related]
7. Reliability and Validity of the Korean Version of the Lymphedema Quality of Life Questionnaire in Breast Cancer-Related Lymphedema Patients.
Uhm KE; Yeo SM; Yoo JS; Hwang JH
Lymphat Res Biol; 2023 Apr; 21(2):187-193. PubMed ID: 35914092
[No Abstract] [Full Text] [Related]
8. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
[TBL] [Abstract][Full Text] [Related]
9. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
Zhang Z; Zhang X; Wei L; Lin Y; Wu D; Xie S; Yue L; Tian J; Zhang Y; Song Q; Woo SM; Miller AR; Luo L; Zhang L
Breast; 2017 Apr; 32():87-92. PubMed ID: 28068605
[TBL] [Abstract][Full Text] [Related]
10. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
Durber K; Halkett GK; McMullen M; Nowak AK
Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
[TBL] [Abstract][Full Text] [Related]
11. Psychometric Evaluation of a Korean Version of the Cancer Survivors' Self-efficacy Scale.
Kim SH; Lee BG; Lee JY; Kim SJ; Hur MH; Lee MH; Han MS
Cancer Nurs; 2019; 42(6):509-514. PubMed ID: 30601268
[TBL] [Abstract][Full Text] [Related]
12. Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29).
Kim KI; Kim JH; Ji EH; Jang JH; Kim JS; Kwon JH; Kim I; Park S; Velikova G; Yoon SS; Oh JM
Qual Life Res; 2016 Apr; 25(4):881-90. PubMed ID: 26342931
[TBL] [Abstract][Full Text] [Related]
13. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
[TBL] [Abstract][Full Text] [Related]
14. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
Gadisa DA; Gebremariam ET; Ali GY
Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
[TBL] [Abstract][Full Text] [Related]
15. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.
Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS
Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079
[TBL] [Abstract][Full Text] [Related]
16. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors.
Kang D; Kim Y; Lim J; Yoon J; Kim S; Kang E; Nam H; Shim S; Lee M; Bok H; Lee SW; Shin SY; Ahn JS; Oh D; Cho J
Cancer Res Treat; 2022 Jan; 54(1):10-19. PubMed ID: 33848414
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two validated instruments to measure financial hardship in cancer survivors: comprehensive score for financial toxicity (COST) versus personal financial wellness (PFW) scale.
D'Rummo KA; Nganga D; Chollet-Hinton L; Shen X
Support Care Cancer; 2022 Dec; 31(1):12. PubMed ID: 36513902
[TBL] [Abstract][Full Text] [Related]
19. The European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 Breast Cancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patients.
El Fakir S; Abda N; Bendahhou K; Zidouh A; Bennani M; Errihani H; Benider A; Bekkali R; Nejjari C
BMC Res Notes; 2014 Jan; 7():53. PubMed ID: 24447401
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Validation of the Korean Version of the Cancer Survivors' Unmet Needs (CaSUN) Scale among Korean Non-Small Cell Lung Cancer Survivors.
Kang D; Lee G; Kim S; Nam H; Kong S; Shim S; Lee JK; Jung W; Shin S; Kim HK; Zo JI; Shim YM; Shin DW; Cho J
Cancer Res Treat; 2023 Jan; 55(1):61-72. PubMed ID: 35209702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
